Emergent BioSolutions, Inc. (EBS)
6.23
0.00 (0.00%)
USD |
NYSE |
Oct 23, 16:00
6.24
+0.01
(+0.16%)
After-Hours: 20:00
Emergent BioSolutions Price to Book Value : 0.9361 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 0.9361 |
| October 22, 2026 | 0.9361 |
| October 21, 2026 | 0.9316 |
| October 20, 2026 | 0.9452 |
| October 19, 2026 | 0.9557 |
| October 16, 2026 | 0.9587 |
| October 15, 2026 | 1.079 |
| October 14, 2026 | 1.038 |
| October 13, 2026 | 1.038 |
| October 12, 2026 | 1.049 |
| October 09, 2026 | 1.061 |
| October 08, 2026 | 1.023 |
| October 07, 2026 | 1.062 |
| October 06, 2026 | 1.044 |
| October 05, 2026 | 1.088 |
| October 02, 2026 | 0.9512 |
| October 01, 2026 | 0.9572 |
| September 30, 2026 | 0.9917 |
| September 29, 2026 | 1.040 |
| September 28, 2026 | 1.031 |
| September 25, 2026 | 1.020 |
| September 24, 2026 | 1.017 |
| September 23, 2026 | 1.002 |
| September 22, 2026 | 1.016 |
| September 21, 2026 | 0.9842 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.022 |
| September 17, 2026 | 1.055 |
| September 16, 2026 | 1.014 |
| September 15, 2026 | 0.9557 |
| September 14, 2026 | 0.9587 |
| September 11, 2026 | 0.9361 |
| September 10, 2026 | 0.882 |
| September 09, 2026 | 0.8535 |
| September 08, 2026 | 0.9016 |
| September 04, 2026 | 0.9331 |
| September 03, 2026 | 0.9361 |
| September 02, 2026 | 0.9707 |
| September 01, 2026 | 0.9346 |
| August 31, 2026 | 0.9166 |
| August 28, 2026 | 0.8881 |
| August 27, 2026 | 0.8926 |
| August 26, 2026 | 0.8971 |
| August 25, 2026 | 0.8475 |
| August 24, 2026 | 0.7784 |
| August 21, 2026 | 0.7633 |
| August 20, 2026 | 0.7243 |
| August 19, 2026 | 0.7348 |
| August 18, 2026 | 0.7002 |
| August 17, 2026 | 0.6762 |
| August 14, 2026 | 0.6897 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Exelixis, Inc. | 8.711 |
| Arcturus Therapeutics Holdings, Inc. | 1.628 |
| Capricor Therapeutics, Inc. | 1.400 |
| ADMA Biologics, Inc. | 5.896 |
| Akebia Therapeutics, Inc. | 6.157 |
Price to Book Value Related Metrics
| PS Ratio | 0.4388 |
| Price to Free Cash Flow | 3.934 |
| Price | 6.23 |
| Earnings Yield | -57.04% |
| Market Cap | 319.60M |
| Operating PE Ratio | 2.469 |